Leading International Investment Research

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Leading International Investment Research, Edison Investment Research

Equity Bottom-Up

Basilea Pharmaceutica Ag / Equity Bottom-Up

<p>Basilea Pharmaceutica has announced that it will in-license a pre-clinical programme of novel broad spectrum anti-fungals targeting difficult-to-treat mould infections. Although the financial implications are limited, this is the first step in management’s plans announced in February to strategically refocus on its core anti-infective business while exploring strategic options for its oncology assets. </p>

Basilea Pharmaceutica has announced that it will in-license a pre-clinical programme of novel broad spectrum anti-fungals targeting difficult-to-treat mould infections. Although the financial implications are limited, this is the first step in management’s plans announced in February to strategically refocus on its core anti-infective business while exploring strategic options for its oncology assets. 

Basilea Pharmaceutica - Spring into a new strategy